期刊文献+

帕金森病患者伴发便秘的临床特征及其对生活质量的影响 被引量:5

Clinical characteristics of Parkinson's disease patients with constipation and its effect on quality of life
下载PDF
导出
摘要 目的探讨帕金森病(PD)伴发便秘患者的临床特征、影响因素及其对生活质量的影响。方法采用自行设计的调查表连续收集2018年3~9月就诊于西安交通大学第一附属医院神经内科的122例PD患者的临床资料。按罗马Ⅲ功能性便秘诊断标准确定有无便秘、Wexner量表评价便秘严重程度、采用非运动评价量表(NMSS)评价非运动症状、统一的帕金森病评定量表(UPDR)Ⅲ部分评价运动症状的严重程度、改良的Hoehn-Yahr分级评价疾病严重程度、帕金森病患者生活质量问卷-39(PDQ-39)评定生活质量。根据资料的性质采用相应的统计学方法分析PD患者伴或不伴有便秘的影响因素。结果122例PD患者中伴发便秘者71例(58.20%),29例(40.85%)便秘发生于运动症状之前,平均5(2.0,11.5)年;随着Hoehn-Yahr分级增加,便秘发生率随之增加,但差异无统计学意义(P>0.05),便秘严重程度也随之增加,差异有显著统计学意义(P<0.01);便秘组患者的年龄、起病年龄、改良的Hoehn-Yahr分级、异动症发生、左旋多巴和多巴胺受体激动剂使用率、UPDRSⅢ评分、NMSS评分和PDQ-39评分明显大于非便秘组,差异均有统计学意义(P<0.05);相关性分析显示:便秘发生与病程、Hoehn-Yahr分级、NMSS评分、UPDRSⅢ评分、PDQ-39评分呈正相关(r=0.48、0.24、0.26、0.25、0.29,P<0.05);Logistic回归分析显示:NMSS评分为便秘发生的唯一独立危险因素(P<0.01);PDQ-39分值和年龄、Hoehn-Yahr分级、UPDRSⅢ评分、NMSS评分及Wexner评分呈正相关(r=0.52、0.62、0.70、0.82、0.51,P<0.01);线性回归分析显示:性别、Hoehn-yahr分级、UPDRSⅢ和Wexner评分是影响PDQ-39评分的危险因素(P<0.05)。结论便秘是PD患者非常常见的非运动症状,伴发便秘的患者生活质量更差。 Objective To discuss the clinical characteristics and influencing factors of Parkinson's disease(PD)patients with constipation,and their effects on quality of life.Methods A total of 122 patients with Parkinson's disease were recruited by a self-designed questionnaire.RomeⅢdiagnostic criteria of functional constipation was used to evaluate constipation.Wexner was used to measure the severity of constipation.Non-motor symptoms scale(NMSS)was used to evaluate non-motor symptoms.Unified Parkinson's disease rating scaleⅢ(UPDRSⅢ)was used to evaluate the severity of motor symptoms.Severity of illness was evaluated by the modified Hoehn-Yahr stages.Parkinson’s disease questionnaire-39 items(PDQ-39)were used to evaluate the quality of life.The corresponding statistical methods were used to analyze the difference of PD patients with or without constipation.Results Among the 122 patients,71(58.20%)was associated with constipation,of which 29(40.85%)experienced constipation before motor symptoms,for an average of 5(2.0,11.5)years.The incidence of constipation increased(P>0.05)and the severity of constipation increased(P<0.01)with the progression of the modified Hoehn-Yahr stages.Compared to patients without constipation,PD patients with constipation had older age,earlier onset age,higher modified Hoehn-Yahr grade,higher occurrence of dyskinesia higher use rate of levodopa and dopamine receptor agonists,and higher scores of UPDRSⅢ,PDQ-39,and NMSS(P<0.05).Correlation analysis showed that constipation was positively correlated with disease duration,the modified Hoehn-Yahr stages,NMSS scores,UPDRSⅢscores,and PDQ-39 scores(r=0.48,0.24,0.26,0.25,0.29,P<0.05).Logistic regression analysis showed that NMSS score was an independent risk factor for constipation.PDQ-39 score was positively correlated with age,modified Hoehn-Yahr stages,NMSS scores,UPDRSⅢscores,NMSS scores,and Wexner scores(r=0.52,0.62,0.70,0.82,0.51,P<0.01).The linear regression analysis showed that gender,Hoehn-yahr grade,UPDRSⅢscore,and Wexner score were independent risk factors that affected the PDQ-39 score(P<0.05).Conclusion Constipation is a common non-motor symptom in patients with PD.Complication with constipation lead to worse quality of life.
作者 孙百花 王涛 乔晋 SUN Bai-hua;WANG Tao;QIAO Jin(Department of Neurology,the First Affiliated Hospital of Xi'an Jiaotong University,Xi'an 710061,Shaanxi,CHINA;Department of Neurology,Shaanxi Sengong Hospital,Xi'an 710300,Shaanxi,CHINA;Department of Rehabilitation Medicine,the First Affiliated Hospital of Xi'an Jiaotong University,Xi'an 710061,Shaanxi,CHINA)
出处 《海南医学》 CAS 2021年第2期148-152,共5页 Hainan Medical Journal
基金 陕西省重点研发计划项目(编号:NO.2018SF-016)。
关键词 帕金森病 便秘 临床特征 影响因素 生活质量 Parkinson's disease Constipation Clinical characteristics Relative factors Quality of life
  • 相关文献

参考文献2

二级参考文献20

  • 1Staffan Holmqvist,Oldriska Chutna,Luc Bousset,Patrick Aldrin-Kirk,Wen Li,Tomas Bj?rklund,Zhan-You Wang,Laurent Roybon,Ronald Melki,Jia-Yi Li.Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats[J]. Acta Neuropathologica . 2014 (6)
  • 2W. Y.‐Y. Wu,K.‐H. Kang,S. L.‐S. Chen,S. Y.‐H. Chiu,A. M.‐F. Yen,J. C.‐Y. Fann,C.‐W. Su,H.‐C. Liu,C.‐Z. Lee,W.‐M. Fu,H.‐H. Chen,H.‐H. Liou.Hepatitis C virus infection: a risk factor for P arkinson’s disease[J]. J Viral Hepat . 2015 (10)
  • 3Thomas Clairembault,Laurène Leclair‐Visonneau,Michel Neunlist,Pascal Derkinderen.Enteric glial cells: New players in Parkinson’s disease?[J]. Mov Disord. . 2015 (4)
  • 4Filip Scheperjans,Velma Aho,Pedro A. B. Pereira,Kaisa Koskinen,Lars Paulin,Eero Pekkonen,Elena Haapaniemi,Seppo Kaakkola,Johanna Eerola‐Rautio,Marjatta Pohja,Esko Kinnunen,Kari Murros,Petri Auvinen.Gut microbiota are related to Parkinson’s disease and clinical phenotype[J]. Mov Disord. . 2015 (3)
  • 5Joaquin A. Vizcarra,Hilary E. Wilson‐Perez,Alberto J. Espay.The power in numbers: Gut microbiota in Parkinson’s disease[J]. Mov Disord. . 2015 (3)
  • 6Mayer, Emeran A,Tillisch, Kirsten,Gupta, Arpana.Gut/brain axis and the microbiota[J]. Journal of Clinical Investigation . 2015 (3)
  • 7Coad Thomas Dow.M. Paratuberculosis and Parkinson’s Disease - Is this a Trigger -[J]. Medical Hypotheses . 2014
  • 8Yu-Ting Sui,Kristin M. Bullock,Michelle A. Erickson,Jing Zhang,W.A. Banks.Alpha synuclein is transported into and out of the brain by the blood–brain barrier[J]. Peptides . 2014
  • 9Thomas Clairembault,Willem Kamphuis,Laurène Leclair‐Visonneau,Malvyne Rolli‐Derkinderen,Emmanuel Coron,Michel Neunlist,Elly M. Hol,Pascal Derkinderen.Enteric GFAP expression and phosphorylation in Parkinson’s disease[J]. J. Neurochem. . 2014 (6)
  • 10N. Malek,D. Swallow,K. A. Grosset,O. Anichtchik,M. Spillantini,D. G. Grosset.Alpha‐synuclein in peripheral tissues and body fluids as a biomarker for P arkinson’s disease – a systematic review[J]. Acta Neurol Scand . 2014 (2)

共引文献77

同被引文献114

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部